These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12119194)
1. Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice. van de Poll SW; Delsing DJ; Jukema JW; Princen HM; Havekes LM; Puppels GJ; van der Laarse A Atherosclerosis; 2002 Sep; 164(1):65-71. PubMed ID: 12119194 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice. Delsing DJ; Jukema JW; van de Wiel MA; Emeis JJ; van der Laarse A; Havekes LM; Princen HM J Cardiovasc Pharmacol; 2003 Jul; 42(1):63-70. PubMed ID: 12827028 [TBL] [Abstract][Full Text] [Related]
3. Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice. van De Poll SW; Römer TJ; Volger OL; Delsing DJ; Bakker Schut TC; Princen HM; Havekes LM; Jukema JW; van Der Laarse A; Puppels GJ Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1630-5. PubMed ID: 11597937 [TBL] [Abstract][Full Text] [Related]
4. Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice. van de Poll SW; Delsing DJ; Wouter Jukema J; Princen HM; Havekes LM; Puppels GJ; van der Laarse A J Mol Cell Cardiol; 2003 Jan; 35(1):109-18. PubMed ID: 12623305 [TBL] [Abstract][Full Text] [Related]
5. Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice. Trion A; de Maat M; Jukema W; Maas A; Offerman E; Havekes L; Szalai A; van der Laarse A; Princen H; Emeis J J Cardiovasc Pharmacol; 2006 Jan; 47(1):89-95. PubMed ID: 16424791 [TBL] [Abstract][Full Text] [Related]
6. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice. Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice. Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345 [TBL] [Abstract][Full Text] [Related]
10. Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy. Jukema JW; van der Hoorn JW Expert Opin Pharmacother; 2004 Feb; 5(2):459-68. PubMed ID: 14996641 [TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice. Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709 [TBL] [Abstract][Full Text] [Related]
12. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy]. Simonyi G; Ferenci T Orv Hetil; 2016 Mar; 157(11):425-9. PubMed ID: 26947091 [TBL] [Abstract][Full Text] [Related]
13. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458 [TBL] [Abstract][Full Text] [Related]
15. Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients. Leibovitz E; Beniashvili M; Zimlichman R; Freiman A; Shargorodsky M; Gavish D Am J Hypertens; 2003 Sep; 16(9 Pt 1):715-8. PubMed ID: 12944027 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605 [TBL] [Abstract][Full Text] [Related]
17. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis. Martín-Ventura JL; Muñoz-Garcia B; Blanco-Colio LM; Martín-Conejero A; Madrigal-Matute J; Vega M; Ortega L; Serrano J; Egido J Kidney Int Suppl; 2008 Dec; (111):S71-4. PubMed ID: 19034332 [TBL] [Abstract][Full Text] [Related]
18. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin. Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386 [TBL] [Abstract][Full Text] [Related]
19. Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats. Zhang X; Deguchi S; Deguchi K; Ohta Y; Yamashita T; Shang J; Tian F; Liu N; Liu W; Ikeda Y; Matsuura T; Abe K J Neurosci Res; 2011 Aug; 89(8):1228-34. PubMed ID: 21538457 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]